Diabetes

The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.

Latest News

Semaglutide. | Image Credit: K KStock - stock.adobe.com
Semaglutide Linked to Lower Dementia Risk in Type 2 Diabetes

June 24th 2025

An analysis of 1.7 million patients shows semaglutide may significantly reduce Alzheimer and vascular dementia risk compared with other diabetes drugs.

Type 2 diabetes - greenapple78 - stock.adobe.com
Previsit Tools Boost Diabetes Deprescribing in Older Adults, Study Finds

June 23rd 2025

Diabetic man | Image credit: Krakenimages.com - stock.adobecom
Addressing Barriers to Hispanic Men's Engagement in Diabetes Prevention

June 18th 2025

Liver disease | Image credit: Crystal light - stock.adobe.com
Fatty Liver Found in Half of Patients With Type 2 Diabetes, Study Finds

June 13th 2025

DASH diet | Image credit: Albi - stock.adobe.com
DASH-Style Diet Lowers Blood Pressure in Type 2 Diabetes

June 10th 2025

Advancing Care in Type 2 Diabetes and Obesity: A Coordinated, Guideline-Driven Approach

Understand how recent advances in GLP-1 receptor agonists and other therapies are transforming the treatment of type 2 diabetes and obesity through a shift of reactive to proactive care that addresses root causes of cardiometabolic disease.

AJMC Peer Exchange geometric background
Continuing Medical Education
View All
June 29th 2025

The Economics of Transthyretin-Mediated Amyloidosis: Balancing Equity and Access in Resource Allocation

1 Credit / Cardiology, Neurology
June 29th 2025

Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care

1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health

More News

Site Logo
March 6th 2018

Music Makes a Difference During Cardiac Stress Tests, Study Finds

Mary Caffrey
The study will be presented during the 67th American College of Cardiology Scientific Session in Orlando, Florida.
What We're Reading: Azar to Announce Healthcare Actions; Opposition to CMS Opioid Limits; Diabetes Disagreement
March 6th 2018

What We're Reading: Azar to Announce Healthcare Actions; Opposition to CMS Opioid Limits; Diabetes Disagreement

AJMC Staff
HHS Secretary Alex Azar said the administration will announce actions to lower healthcare costs, as well as a move to give patients control of their data; doctors and patients with chronic pain oppose proposed prescribing limits sought by CMS for opioids; doctor groups are disagreeing about blood sugar targets for patients with diabetes.
Novo Nordisk Announces Phase 3a Trial Results for Oral Semaglutide
February 26th 2018

Novo Nordisk Announces Phase 3a Trial Results for Oral Semaglutide

Samantha DiGrande
On Friday, Novo Nordisk announced the results from PIONEER 1, a phase 3a trial featuring oral semaglutide for treatment of adults with type 2 diabetes (T2D). Oral semaglutide is a new glucagon-like peptide-1 (GLP-1) analogue taken once daily as a tablet, making this investigational therapy the first oral treatment in this class.
Early Look at ACC Navigator Program Shows Inpatient Mortality Drops as Hospitals Take Positive Steps
February 26th 2018

Early Look at ACC Navigator Program Shows Inpatient Mortality Drops as Hospitals Take Positive Steps

Mary Caffrey
In the next phase of the program, researchers will dig into the data they have gathered so far to identify the best practices for reducing 30- and 90-day readmission rates.
Brenda Schmidt Discusses Educating People on Their Type 2 Diabetes Risk
February 22nd 2018

Brenda Schmidt Discusses Educating People on Their Type 2 Diabetes Risk

There is a lot of energy around educating consumers about their risk for type 2 diabetes, explained Brenda Schmidt, CEO of Solera Health.
Podcast: This Week in Managed Care—Rising Healthcare Spending and Other Health News
February 17th 2018

Podcast: This Week in Managed Care—Rising Healthcare Spending and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: February 16, 2018
February 16th 2018

This Week in Managed Care: February 16, 2018

This week, the top managed care stories included a report from CMS that found healthcare spending will rise 5.5% over the next 8 years; the budget deal passed by Congress included a number of provisions with long-term health impact; a study found eating a low-carb could help reverse type 2 diabetes.
Site Logo
February 16th 2018

Leveraging Benefit Design for Better Diabetes Self-Management and A1C Control

Abiy Agiro, PhD Yiqiong Xie, PhD Kevin Bowman, MD Andrea DeVries, PhD
Patients with diabetes receiving insulin treatment with lower cost sharing for blood glucose testing strips were more likely to achieve glycemic control than those with higher cost sharing.
Roche Acquires Flatiron Health for $1.9 Billion
February 16th 2018

Roche Acquires Flatiron Health for $1.9 Billion

Mary Caffrey
Flatiron Health expects to maintain its current business model in the transaction.
In Real-World Study, Toujeo Reduced Risks of Severe Hypoglycemia Compared With Older Insulins
February 15th 2018

In Real-World Study, Toujeo Reduced Risks of Severe Hypoglycemia Compared With Older Insulins

Mary Caffrey
The study used a claims database to examine records from patients who switched between long-acting insulins.
Congress Includes Language Protecting the Rights of Diabetes Patients in Budget Deal
February 14th 2018

Congress Includes Language Protecting the Rights of Diabetes Patients in Budget Deal

Kaitlynn Ely
Language in the new government budget ensures effective changes to CMS' Competitive Bidding Program for diabetes testing supplies that will benefit patients with diabetes.
Gallup-Sharecare: Sense of Well-Being Sees Biggest Drop Since Great Recession
February 13th 2018

Gallup-Sharecare: Sense of Well-Being Sees Biggest Drop Since Great Recession

Mary Caffrey
Such a large drop in Americans' sense of well-being in their daily lives in a time of economic good fortune is unprecedented, index organizers say.
Site Logo
February 13th 2018

After a Year, Low-Carb Diet Helps Many Patients Reverse Type 2 Diabetes, Lose Weight, and Stop Insulin

Mary Caffrey
Of the 262 patients with type 2 diabetes in the intervention, 83% stuck with it through the first year, despite significant requirements.
Study Finds Exposure to Areas With High Overweight/Obesity Rates Affects BMI
February 12th 2018

Study Finds Exposure to Areas With High Overweight/Obesity Rates Affects BMI

Kaitlynn Ely
An individual’s body mass index (BMI) can increase when exposed to counties with a higher prevalence of obesity, according to a study published in JAMA Pediatrics.
Medicare Continues to Fight CGM Coverage in Court, and Told to Pay
February 3rd 2018

Medicare Continues to Fight CGM Coverage in Court, and Told to Pay

Mary Caffrey
Despite an official policy since early 2017 that calls for Medicare to cover CGM for certain beneficiaries with diabetes, an attorney who won a landmark case prior to the policy change reports that beneficiaries are still being denied coverage.
Podcast: This Week in Managed Care—State of the Union and Other Health News
February 3rd 2018

Podcast: This Week in Managed Care—State of the Union and Other Health News

Laura Joszt, MA
Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: February 2, 2018
February 2nd 2018

This Week in Managed Care: February 2, 2018

This week, the top managed care news included President Donald Trump vowing to lower drug prices during his State of the Union address; 3 corporate giants joined forces on healthcare; and CAR T-cell therapy was named the cancer advance of the year.
Prime Therapeutics, Boehringer-Ingelheim Reach Outcomes-Based Contract for Jardiance
January 30th 2018

Prime Therapeutics, Boehringer-Ingelheim Reach Outcomes-Based Contract for Jardiance

Mary Caffrey
Empagliflozin (Jardiance) and another SGLT2 inhibitor, canagliflozin (Invokana) have been competing aggressively; both have clinical trial results showing cardiovascular benefits.
Site Logo
January 29th 2018

Omada Health Diabetes Prevention Trial to Track Healthcare Utilization

Mary Caffrey
Officials at Omada Health said the PREDICTS trial was planned long before CMS decided not to include virtual providers in this spring's launch of the Medicare Diabetes Prevention Program. But a spokesperson said the company hopes the growing body of evidence in support of virtual programs will "assuage any concerns."
Solera Health, WellDoc Partnership a "Natural Evolution" That Will Address Diabetes Prevention, Management
January 19th 2018

Solera Health, WellDoc Partnership a "Natural Evolution" That Will Address Diabetes Prevention, Management

Mary Caffrey
The pairing will give employers and health plans "holistic" solutions for chronic disease management, according to CEOs of the companies.
Site Logo
January 17th 2018

Bridging the Digital Divide: Mobile Access to Personal Health Records Among Patients With Diabetes

Ilana Graetz, PhD Jie Huang, PhD Richard J. Brand, PhD John Hsu, MD, MBA, MSCE Cyrus K. Yamin, MD Mary E. Reed, DrPH
Racial/ethnic minorities and patients living in poorer neighborhoods were more likely to access their personal health record exclusively with a mobile device.
Podcast: This Week in Managed Care—New Voluntary Payment Model and Other Health News
January 13th 2018

Podcast: This Week in Managed Care—New Voluntary Payment Model and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
After Long Wait, Omnipod Achieves Coverage Through Medicare Part D
January 13th 2018

After Long Wait, Omnipod Achieves Coverage Through Medicare Part D

Mary Caffrey
This Week in Managed Care: January 12, 2018
January 12th 2018

This Week in Managed Care: January 12, 2018

This week, the top managed care stories included CMS unveiling a new voluntary bundled payment model; coverage from the JP Morgan Healthcare Conference, including immunotherapy's impact on HIV treatment and biosimilars; and news that 2 key diabetes devices will be covered by Medicare.
Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds
January 12th 2018

Chronic Inflammation, Dyslipidemia Puts Children, Teens With HIV at Higher CV Risk, Study Finds

Mary Caffrey
The same mechanisms that cause those with long-term HIV infection to suffer higher rates of heart attacks or strokes put children born with disease at early risk of cardiovascular disease, according to a new study.
5 Things From the 36th Annual JP Morgan Healthcare Conference
January 12th 2018

5 Things From the 36th Annual JP Morgan Healthcare Conference

Kelly Davio
This week, the investors and analysts turned their attention to presentations by business leaders at the 36th Annual JP Morgan Healthcare Conference, held in San Francisco, California. Executives from the pharmaceutical and healthcare worlds showcased their products, pipelines, and visions for the future.
Study Shows the Impact Synchronization Programs Have on Medication Adherence
January 10th 2018

Study Shows the Impact Synchronization Programs Have on Medication Adherence

Kaitlynn Ely
Older adults who are prescribed many medications that require frequent trips to the pharmacy are more likely to not refill their prescriptions on time, but patients who participate in medication synchronization programs have improved adherence to cardiovascular medications, according to a study published in Health Affairs.
A Leader in Diabetes Prevention Gets Ready to Help Medicare Reach Seniors Everywhere
January 10th 2018

A Leader in Diabetes Prevention Gets Ready to Help Medicare Reach Seniors Everywhere

Mary Caffrey
Brenda Schmidt, CEO of Solera Health, discusses the historic launch of the Medicare Diabetes Prevention Program scheduled for this April and how her company is helping providers and other stakeholders get ready.
The Importance of Adding the Diabetes Prevention Program to Medicare
January 10th 2018

The Importance of Adding the Diabetes Prevention Program to Medicare

Brenda Schmidt is CEO of Solera Health, an integrator that serves as the “back office” for both community-based and digital providers of the Diabetes Prevention Program (DPP), an evidence-based program that has been shown to reduce incidence of people with prediabetes progressing to type 2 diabetes. In April, Medicare will take the historic step of launching the DPP for beneficiaries, and Solera has been at the forefront of helping providers navigate the policy and technical hurdles to serve clients who will take part in the DPP.
Site Logo
January 9th 2018

Medical World News: Regulatory Updates

AJMC Staff
<1
...
282930313233343536
...
98>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo